Authors: Lioudyno, MI Verbitsky, M Holt, JC Elgoyhen, AB Guth, PS

Citation: Mi. Lioudyno et al., Morphine inhibits an alpha 9-acetylcholine nicotinic receptor-mediated response by a mechanism which does not involve opioid receptors, HEARING RES, 149(1-2), 2000, pp. 167-177

Authors: Katz, E Verbitsky, M Rothlin, CV Vetter, DE Heinemann, SF Elgoyhen, AB

Citation: E. Katz et al., High calcium permeability and calcium block of the alpha 9 nicotinic acetylcholine receptor, HEARING RES, 141(1-2), 2000, pp. 117-128

Authors: Verbitsky, M Rothlin, CV Katz, E Elgoyhen, AB

Citation: M. Verbitsky et al., Mixed nicotinic-muscarinic properties of the alpha 9 nicotinic cholinergicreceptor, NEUROPHARM, 39(13), 2000, pp. 2515-2524

Authors: Rothlin, CV Katz, E Verbitsky, M Vetter, DE Heinemann, SF Elgoyhen, AB

Citation: Cv. Rothlin et al., Block of the alpha 9 nicotinic receptor by ototoxic aminoglycosides, NEUROPHARM, 39(13), 2000, pp. 2525-2532

Authors: Verbitsky, M

Citation: M. Verbitsky, Hypercomplex varieties, COMMUN AN G, 7(2), 1999, pp. 355-396

Authors: Rothlin, CV Katz, E Verbitsky, M Elgoyhen, AB

Citation: Cv. Rothlin et al., The alpha 9 nicotinic acetylcholine receptor shares pharmacological properties with type a gamma-aminobutyric acid, glycine, and type 3 serotonin receptors, MOLEC PHARM, 55(2), 1999, pp. 248-254